Skip to main content
. Author manuscript; available in PMC: 2022 Feb 17.
Published in final edited form as: J Infect Dis. 2020 Jan 14;221(3):367–371. doi: 10.1093/infdis/jiz472

Table 1.

In Vitro Characterization of Influenza A Viruses Used in This Study

Predicted Amino Acid Substitution vs Controlaa
Virus Titer, AUC8-72 Mean ± SE (%Difference)e
Subtype Virus PA Proteinb Other Proteins Sequence Accessionc EPI_ISL_ Baloxavir EC50, nM, Mean ± SD (Fold Increase vs Control)d MDCK MDCK-SIAT1
H1N1pdm09 A/Illinois/08/2018 Control Control 315855 1.82 ± 0.39 (1) 364.6 ± 8.5 334.8 ± 13.4
I38Tf HA: K119N 348120 92.00 ± 12.00 (51) 321.8 ± 15.5 (−12)* 316.0 ± 4.1 (−6)
I38Sf - 365522 94.13 ± 9.82 (52) 327.8 ± 9.4 (−10)* 300.5 ± 4.7 (−10)
A/Illinois/37/2018 I38L PA-X: E209G 315856 16.69 ± 6.41 (9) 382.2 ± 4.3 (+5) 350.0 ± 6.8 (+5)
H3N2 A/Louisiana/50/2017 Control Control 315857 1.31 ± 0.35 (1) 342.6 ± 11.8 358.5 ± 11.4
A/Louisiana/49/2017 I38M - 315858 13.58 ± 2.59 (10) 317.8 ± 11.6 (−7) 323.6 ± 7.0 (−10)*
A/Bangladesh/3007/2017g Control Control 340421 1.33 ± 0.39 (1) 212.5 ± 9.8 238.8 ± 6.8
I38T NA: T71I 340405 153.82 ± 15.90 (116) 185.0 ± 9.5 (−13) 218.7 ± 4.6 (−8)*

Abbreviations: AUC8–72, area under the curve for 8–72 hours postinfection; EC50, 50% effective concentration; HA, hemagglutinin; MDCK, Madin-Darby canine kidney cells; NA, neuraminidase; PA, polymerase acidic protein; PA-X, PA-X protein; SD, standard deviation; SE, standard error.

a

Comparison of the codon-complete genome sequences of a PA-I38-substituted virus and its respective control virus. Only amino acid substitutions are shown.

b

PA and PA-X proteins share the same amino acid at residue 38; only additional changes in PA-X are shown in Table 1.

c

Genome sequences deposited to Global Initiative on Sharing All Influenza Data ([GISAID] https://www.gisaid.org/); PA-I38-substituted viruses have 1–4 silent nucleotide changes compared with the genomes of their respective control viruses.

d

Baloxavir EC50 results are shown as mean ± SD of at least 3 independent tests. The fold increase was determined by comparing the EC50 of PA-substituted virus with the respective control virus.

e

The percentage difference was determined by comparing the mean AUC value of PA-substituted virus with that of the respective control virus (set at 100%).

*

indicates statistical significant (P < .05) difference between AUC8–72 for PA-I38-substituted virus and its control.

f

Viruses carrying I38T and I38S were selected in MDCK cells in the presence of baloxavir and purified by limiting dilution.

g

A/Bangladesh/3007/2017 virus isolate (GISAID ID: S2 isolate EPI_ISL_286069; original specimen EPI_ISL_282881) contained viral subpopulations with I38 or I38T in PA protein, which were separated by limiting dilution.